WAVE Life Sciences Gets Orphan Drug States From FDA For Lead Candidate To Treat Huntington's Disease

By: via Benzinga
WAVE Life Sciences Ltd. (NASDAQ: WVE) revealed that its lead candidate WVE-120101, which is being investigated for the treatment of ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.